Hydrea



Indications and Reactions:

Role Indications Reactions
Primary
Essential Thrombocythaemia 17.8%
Polycythaemia Vera 11.8%
Chronic Myeloid Leukaemia 11.3%
Acute Myeloid Leukaemia 6.6%
Thrombocytosis 6.0%
Thrombocytopenia 5.1%
Platelet Count Increased 4.9%
Polycythaemia 4.5%
Breast Cancer 4.1%
Sickle Cell Anaemia 3.6%
Myelofibrosis 3.4%
Hypertension 3.0%
Myelodysplastic Syndrome 3.0%
Bile Duct Cancer 2.6%
Diabetes Mellitus 2.6%
Myeloproliferative Disorder 2.6%
Psoriasis 2.1%
Thrombocythaemia 2.1%
Bronchopulmonary Aspergillosis 1.5%
Atrial Fibrillation 1.3%
Pyrexia 11.9%
Interstitial Lung Disease 9.8%
Skin Ulcer 7.7%
Vomiting 6.3%
Haemorrhage 5.6%
Renal Failure 5.6%
Death 4.9%
Squamous Cell Carcinoma 4.9%
Thrombocytopenia 4.9%
Pancytopenia 4.2%
White Blood Cell Count Decreased 4.2%
Anaemia 3.5%
Cerebrovascular Accident 3.5%
Macrocytosis 3.5%
Malignant Neoplasm Progression 3.5%
Platelet Count Increased 3.5%
Pneumonia 3.5%
Pregnancy 3.5%
Back Pain 2.8%
Breast Cancer 2.8%
Secondary
Chronic Myeloid Leukaemia 14.7%
Product Used For Unknown Indication 11.7%
Acute Myeloid Leukaemia 11.5%
Bronchopulmonary Aspergillosis 9.5%
Essential Thrombocythaemia 8.2%
Langerhans' Cell Granulomatosis 7.7%
Drug Use For Unknown Indication 4.1%
Myelodysplastic Syndrome 3.7%
Hypertension 3.1%
Tongue Neoplasm Malignant Stage Unspecified 3.1%
Glioblastoma Multiforme 3.0%
Breast Cancer 2.9%
Head And Neck Cancer 2.4%
Thrombocytopenia 2.4%
Pyrexia 2.3%
Hypopharyngeal Cancer 2.2%
Polycythaemia Vera 2.2%
Iron Overload 1.9%
Prophylaxis 1.8%
Acute Leukaemia 1.7%
Pyrexia 13.0%
Vomiting 8.7%
White Blood Cell Count Increased 8.7%
Pneumonia 7.2%
White Blood Cell Count Decreased 7.2%
Thrombocytopenia 6.5%
Ventricular Fibrillation 5.8%
Pancytopenia 5.1%
Anaemia 3.6%
Splenomegaly 3.6%
Staphylococcal Infection 3.6%
Viral Infection 3.6%
Cerebellar Syndrome 2.9%
Death 2.9%
Diet Refusal 2.9%
Hepatic Function Abnormal 2.9%
Lung Infection 2.9%
Rash Maculo-papular 2.9%
Renal Failure Acute 2.9%
Skin Disorder 2.9%
Concomitant
Drug Use For Unknown Indication 16.6%
Chronic Myeloid Leukaemia 16.0%
Product Used For Unknown Indication 16.0%
Acute Myeloid Leukaemia 5.5%
Pain 4.9%
Hypertension 4.6%
Prophylaxis 4.6%
Myelodysplastic Syndrome 4.4%
Sickle Cell Anaemia 4.4%
Iron Overload 3.6%
Diabetes Mellitus 3.5%
Myelofibrosis 3.0%
Essential Thrombocythaemia 2.6%
Polycythaemia Vera 1.9%
Unevaluable Event 1.7%
Cardiac Failure 1.7%
Osteoporosis 1.4%
Nausea 1.3%
Myeloproliferative Disorder 1.2%
Atrial Fibrillation 1.1%
Vomiting 14.5%
White Blood Cell Count Decreased 9.6%
Thrombocytopenia 8.6%
Weight Decreased 8.3%
White Blood Cell Count Increased 8.3%
Renal Failure 4.7%
Sickle Cell Anaemia With Crisis 4.4%
Rash 4.2%
Death 3.9%
Electrocardiogram Qt Prolonged 3.7%
Renal Failure Acute 3.7%
Pyrexia 3.4%
Pneumonia 3.2%
Urinary Tract Infection 3.2%
Diarrhoea 2.9%
Nausea 2.9%
Weight Increased 2.9%
Respiratory Failure 2.7%
Acute Myeloid Leukaemia 2.5%
Pain 2.5%
Interacting
Bile Duct Cancer 63.2%
Essential Thrombocythaemia 26.3%
Herpes Zoster 5.3%
Pain 5.3%
Pancytopenia 60.0%
Drug Interaction 20.0%
Pain 20.0%